Cosmetic products in the United States, including glycolic acid body scrubs, do not require pre-market FDA approval — cosmetics are not approved by the FDA the way drugs are. However, following the enactment of the Modernization of Cosmetics Regulation Act (MoCRA) in December 2022, the regulatory landscape shifted meaningfully, and founders who treat cosmetics as a completely unregulated space are making a costly mistake.
Under MoCRA, the following are now mandatory: facility registration (manufacturers and packers of cosmetics must register with the FDA by December 2023 for domestic facilities, December 2024 for small businesses); product listing (each cosmetic product must be listed with the FDA, including all ingredients); serious adverse event reporting (facilities must report adverse events that result in hospitalization, emergency room visits, or other serious outcomes within 15 days); and adequate substantiation of safety (the manufacturer or brand owner must have safety substantiation on file, though it is not submitted to the FDA preemptively).
Glycolic acid at concentrations above 10%, or marketed with drug claims such as "treats acne" or "exfoliates precancerous cells," can trigger OTC drug classification. OTC drugs require FDA monograph compliance or a New Drug Application. To stay in cosmetic territory, claims must describe cosmetic benefits: "visibly smooths rough skin," "brightens the appearance of uneven skin tone," "buffs away dull surface cells." Avoid words like "treats," "heals," "cures," or references to specific skin conditions.
Microbead compliance is also mandatory: the Microbead-Free Waters Act prohibits plastic microbeads in rinse-off cosmetics sold in the US. Any contract manufacturer producing compliant formulas should have eliminated polyethylene or polypropylene beads. Sugar, bamboo, pumice, and rice bran are all compliant alternatives.
For EU sales, a separate regulatory framework applies: EU Cosmetics Regulation (EC) No. 1223/2009 governs all cosmetics, requiring a CPSR (safety report), CPNP notification, and PIF (product information file) maintained by an EU Responsible Person. Glycolic acid falls under Annex III restrictions in the EU, capping rinse-off body products at 10% with mandatory UV-sensitivity labeling.
Working with a manufacturer who has direct experience with MoCRA registration and EU Annex III compliance dramatically reduces your regulatory risk. AJ Cosmo Labs vets manufacturers in the cosmetics category for regulatory literacy, so you can ask directly in the app whether a prospective partner is FDA-registered and has experience preparing CPSRs.
Ingredients in this answer: Glycolic Acid
Read the full guide on Private Label Niacinamide Glycolic Acid Body Scrub – Low MOQ →